These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21054910)

  • 21. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study by scanning electron microscopy on vestibular toxicities of dibekacin, ribostamycin, and other aminoglycoside antibiotics in guinea pigs.
    Sato K; Saito T; Matsuhira T
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):109-14. PubMed ID: 6602100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gentamicin Applied to the Oval Window Suppresses Vestibular Function in Guinea Pigs.
    King EB; Shepherd RK; Brown DJ; Fallon JB
    J Assoc Res Otolaryngol; 2017 Apr; 18(2):291-299. PubMed ID: 28050646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vestibular function at the end of intratympanic gentamicin treatment of patients with Ménière's disease.
    Perez N; Rama-Lopez J
    J Vestib Res; 2005; 15(1):49-58. PubMed ID: 15908740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel inner ear monitoring system for evaluating ototoxicity of gentamicin eardrops in guinea pigs.
    Yang TH; Liu SH; Young YH
    Laryngoscope; 2010 Jun; 120(6):1220-6. PubMed ID: 20513043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin.
    Wagner N; Cayé-Thomasen P; Laurell G; Bagger-Sjöbäck D; Thomsen J
    Acta Otolaryngol; 2005 Apr; 125(4):340-5. PubMed ID: 15823802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled and sustained local gentamicin delivery system for inner ear applications.
    Xu L; Heldrich J; Wang H; Yamashita T; Miyamoto S; Li A; Uboh CE; You Y; Bigelow D; Ruckenstein M; O'Malley B; Li D
    Otol Neurotol; 2010 Sep; 31(7):1115-21. PubMed ID: 20616758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vestibular destruction by slow infusion of gentamicin into semicircular canals.
    Lii M; Ding D; Zheng XY; Salvi R
    Acta Otolaryngol Suppl; 2004 May; (552):35-41. PubMed ID: 15219045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-related vestibular and cochlear effects of transtympanic gentamicin.
    Wanamaker HH; Gruenwald L; Damm KJ; Ogata Y; Slepecky N
    Am J Otol; 1998 Mar; 19(2):170-9. PubMed ID: 9520053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal and spatial distribution of gentamicin in the peripheral vestibular system after transtympanic administration in guinea pigs.
    Zhang R; Zhang YB; Dai CF; Steyger PS
    Hear Res; 2013 Apr; 298():49-59. PubMed ID: 23380663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inner ear effects of topical gentamicin treatment in patients with Menière's disease.
    Bagger-Sjöbäck D; Bergenius J; Lundberg AM
    Am J Otol; 1990 Nov; 11(6):406-10. PubMed ID: 2285060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
    Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
    J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [27 years experiences with transtympanic aminoglycoside treatment of Menière's disease].
    Lange G
    Laryngorhinootologie; 1995 Dec; 74(12):720-3. PubMed ID: 8579669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of subjective visual horizontal after unilateral vestibular deafferentation by intratympanic instillation of gentamicin.
    Takai Y; Murofushi T; Ushio M; Iwasaki S
    J Vestib Res; 2006; 16(1-2):69-73. PubMed ID: 16917170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bromodeoxyuridine immunohistochemical observation of sensory epithelium repair after ototoxic destruction in the crista ampullaris of guinea pigs].
    Lang H; Liu C; Fan E
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(6):341-3. PubMed ID: 9640694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scanning electron microscopic observation of dark cells after streptomycin perfusion of the vestibule in guinea pigs.
    Ge X; Shea JJ
    Scanning Microsc; 1995 Mar; 9(1):283-8. PubMed ID: 8553023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G; Maurer J; Mann W
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.